Stocks · Health care · Biological Products, (No Diagnostic Substances)

CG Oncology, Inc.

CGON Clue Score59

United States Fiscal year ends December CIK 0001991792 Results filed 6 Nov 2026

Add to watchlist

By person

8 insiders · 53 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Brian Guan-Chyun Liu

Director

$74.81M (2)

—

+$74.81M

1,886,236

2.13%

$117.85M

—

Hong Fang Song

Director

$5.00M (1)

$45.38M (7)

−$40.38M

3,517,859

3.97%

$219.80M

—

Decheng Capital Global Life Sciences Fund IV, L.P. entity

10% owner

$7.60M (1)

—

+$7.60M

4,958,812

5.59%

$309.83M

+432.9%

James Mulay

Director

—

$6.28M (16) scheduled

−$6.28M

0.0000%

$0.00

—

Leonard E Post

Director

—

$1.62M (22) scheduled

−$1.62M

0.0000%

$0.00

—

Corleen M. Roche

CFO

$38.00K (1)

—

+$38.00K

2,000

0.0023%

$124.96K

—

Vijay Kasturi

Chief Medical Officer

$24.99K (1)

—

+$24.99K

1,315

0.0015%

$82.16K

—

Arthur Kuan

Chief Executive Officer

—

198,916

0.2244%

$12.43M

+450.2%

CG Oncology, Inc.

What the insiders did Net buying

By person